Board Meeting Details
The Board of Directors meeting will be held on Thursday, November 12, 2026. The primary agenda includes:
- Consideration and approval of Unaudited Standalone Financial Results for the quarter ended September 30, 2026 (Q2 FY 2026-27)
- Consideration and approval of Unaudited Consolidated Financial Results for the quarter ended September 30, 2026 (Q2 FY 2026-27)
- Taking on record the aforementioned financial results
- Any other business matters with the permission of the Chairperson of the Board Meeting
Trading Window Closure
Pursuant to the company's letter dated September 22, 2026, the Trading Window for dealing in securities of the company remains closed for all Designated Persons covered under the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders. The closure period is from October 1, 2026 until 48 hours after the announcement of the Unaudited Standalone & Consolidated Financial Results for the quarter ended September 30, 2026.
Financial Impact
Financial impact not quantified in this disclosure as this is an intimation of upcoming board meeting for results consideration and approval.